Supported by:





Friday, November 20, 2015

20/11/2015: FDA approves AquAdvantage® salmon

https://aquabounty.com/
Image: Amber Strocel
AquaBounty Technologies, Inc, a biotechnology company focused on enhancing productivity in aquaculture, and a majority-owned subsidiary of Intrexon Corporation, announced on November 19 that the US Food and Drug Administration (FDA) has approved the Company’s New Animal Drug Application for the production, sale and consumption of its AquAdvantage® Salmon, an Atlantic salmon that has been genetically enhanced to reach market size in less time than conventional farmed Atlantic salmon.

Ronald L Stotish, PhD, Chief Executive Officer of AquaBounty, commented, “AquAdvantage Salmon is a game-changer that brings healthy and nutritious food to consumers in an environmentally responsible manner without damaging the ocean and other marine habitats. Using land-based aquaculture systems, this rich source of protein and other nutrients can be farmed close to major consumer markets in a more sustainable manner.”

The U.S. currently imports over 90 percent of all the seafood—and more specifically over 95 percent of the Atlantic salmon—it consumes. AquAdvantage Salmon will offer the opportunity for an economically viable domestic aquaculture industry while providing consumers a fresh and delicious product.

Through greater efficiency and localised production, AquaBounty’s AquAdvantage Salmon increases productivity while reducing costs and the environmental impacts associated with current salmon farming operations. Land-based aquaculture systems can provide a continuous supply of fresh, safe, traceable, and sustainable AquAdvantage Salmon to communities across the US and do it with a reduced carbon footprint. Importantly, it offers an alternative approach to fish farming that does not exploit the oceans.

Jack A Bobo, Senior Vice President and Chief Communications Officer at Intrexon, stated, “The US Dietary Guidelines Advisory Committee encourages Americans to eat a wide variety of seafood—including wild caught and farmed—as part of a healthy diet rich in healthy fatty acids. However, this must occur in an environmentally friendly and sustainable manner. FDA’s approval of the AquAdvantage Salmon is an important step in this direction.” 
    
https://aquabounty.com/
Image: Camilo Rueda López
Visit the AquaBounty Technologies site HERE

The Aquaculturists
This blog is maintained by The Aquaculturists staff and is supported by the
magazine International Aquafeed which is published by
Perendale Publishers Ltd

For additional daily news from aquaculture around the world: aquaculture-news

No comments:

Post a Comment